Astellas Partners with Dyno Therapeutics for Gene Therapy Technology
By Lucy Haggerty
Pharma Deals Review: Vol 2021 Issue 12 (Table of Contents)
Published: 9 Dec-2021
DOI: 10.3833/pdr.v2021.i12.2649 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In order to strengthen its gene therapy pipeline, Astellas Pharma has agreed to pay US$18 M upfront and committed up to US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS